The Cigna Group (CI)
Cigna (CI) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Cigna (CI) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cigna CEO David Cordani To Retire And Be Replaced By Internal Choice
The Cigna Group Tuesday said long-time top executive David M. Cordani will retire as chief executive officer effective July 1, 2026, and be replaced by current president and chief operating officer Brian Evanko.
Here's Why Cigna (CI) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Cigna (CI) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cigna (CI) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Cigna Group (CI) Q4 2025 Earnings Call Transcript
The Cigna Group (CI) Q4 2025 Earnings Call Transcript
Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes
CI's Q4 adjusted EPS beats estimates as Evernorth growth and higher specialty volumes offset fewer medical customers and elevated costs.
Make Your Portfolio Healthy Again: The Cigna Group
The Cigna Group stands out as a deeply undervalued healthcare pick, trading at a forward P/E of 9 versus a 10-year average of 13.5. CI targets 10–14% annual adjusted EPS growth long-term, driven by customer growth, pricing, acquisitions, and share repurchases. The stock offers a 2.2% dividend yield with a low payout ratio, supporting continued double-digit dividend growth and a Chowder number near 13.
Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cigna (CI) Q4 Earnings and Revenues Beat Estimates
Cigna (CI) came out with quarterly earnings of $8.08 per share, beating the Zacks Consensus Estimate of $7.87 per share. This compares to earnings of $6.64 per share a year ago.
Cigna Revenue Lifted by Growth in its Evernorth Unit
Cigna Group logged higher revenue in its latest quarter as its pharmacy-benefit business Evernorth continues to grow.
